Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals.

Synexa Life Sciences announces strategic growth plans and strengthening of its executive team

Synexa Life Sciences announces strategic growth plans and strengthening of its executive team

Delivering on growth strategies to become the global market leader in specialist biomarker and bioanalytical services.

Synexa Life Sciences Co-founder and CEO to become company’s Chairman

Synexa Life Sciences Co-founder and CEO to become company’s Chairman

Leading biomarker and bioanalysis company lays the foundation for future growth and expansion plan.

News Signup

"*" indicates required fields

Consent*
This field is for validation purposes and should be left unchanged.

Talk to our Biomarker Experts